PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity
Science Advances · 2025
DOI: 10.1126/sciadv.adw2568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Shen Yang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Altman Clinical and Translational Research Institute, University of California, San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 22, Leukocyte Common Antigens, Receptors, Antigen, T-Cell, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is encoded by a gene strongly associated with lupus and other autoimmune diseases. PTPN22 regulates T cell receptor (TCR) signaling through dephosphorylation of the kinases lymphocyte-specific protein tyrosine kinase (LCK) and zeta-chain–associated protein kinase 70 (ZAP70). The regulation of PTPN22 remains poorly understood. Here, we identify PTPN22 Ser 449 as a protein kinase A phosphorylation site, which is triggered by TCR engagement and is hyperphosphorylated in lupus peripheral blood cells. PTPN22 Ser 449 phosphorylation selectively lowered the affinity of PTPN22 for ZAP70 versus LCK but also indirectly suppressed inhibitory LCK Tyr 192 phosphorylation through a ZAP70-CD45 signaling axis. The resulting dephosphorylation of LCK Tyr 192 not only enhanced TCR signaling but also modulated pathway activation downstream the TCR. In vivo loss of PTPN22 Ser 449 phosphorylation reduced T cell responses and suppressed experimental lupus nephritis. These results suggest that PTPN22 Ser 449 phosphorylation promotes a CD45-mediated retrograde ZAP70-LCK feedback loop that enhances T cell responses and promotes autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Altman Clinical and Translational Research Institute, University of California, San Diego, La Jolla, CA 92093, USA.
- Department of Medicine, Kao Autoimmunity Institute and Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
- Department of Chemical and Nano Engineering, University of California, San Diego, La Jolla, CA 92093, USA.
- Laboratory Animal Center, College of Medicine, National Taiwan University, Taipei 10048, Taiwan.
ORCID-Profile: Shen Yang, Eugenio Santelli, Carlos G Gonzalez, Wade T Johnson, Chuling Zhuang, Leigh-Ana M Rossitto, I-Shing Yu, Shu-Wha Lin, Yuan Zhan, Qinwei Chen, Jonathan D Yoshihara, Daniel J Wallace, Caroline A Jefferies, Michifumi Yamashita, David J Gonzalez, Nisarg J Shah, Nunzio Bottini
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Yang, S., Santelli, E., Gonzalez, C. G., Johnson, W. T., Choi, I. V., Zhuang, C., Ro, M., Rossitto, L. M., Yu, I. S., Lin, S. W., Zhan, Y., Chen, Q., Yoshihara, J. D., Wallace, D. J., Jefferies, C. A., Yamashita, M., Gonzalez, D. J., Ainsworth, R. I., Shah, N. J., …, & Bottini, N. (2025). PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity. Science Advances. https://doi.org/10.1126/sciadv.adw2568
Vancouver
Yang S, Santelli E, Gonzalez CG, Johnson WT, Choi IV, Zhuang C, et al. PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity. Science Advances. 2025. doi:10.1126/sciadv.adw2568
BibTeX
@article{Yang2025,
author = {Yang, Shen and Santelli, Eugenio and Gonzalez, Carlos G and Johnson, Wade T and Choi, Irene V and Zhuang, Chuling and Ro, Myungja and Rossitto, Leigh-Ana M and Yu, I-Shing and Lin, Shu-Wha and Zhan, Yuan and Chen, Qinwei and Yoshihara, Jonathan D and Wallace, Daniel J and Jefferies, Caroline A and Yamashita, Michifumi and Gonzalez, David J and Ainsworth, Richard I and Shah, Nisarg J and Stanford, Stephanie M and Bottini, Nunzio},
title = {PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adw2568}
}
EUVIMED